Acorns Advisers’s CVS Health CVS Stock Holding History

Acorns Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$245K	Buy	3,409 +406	+14%	+$31.3K	﹤0.01%	98
2025 Q4	$238K	Buy	3,003 +119	+4%	+$9.38K	﹤0.01%	95
2025 Q3	$217K	Buy	+2,884	New	+$198K	﹤0.01%	91

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acorns Advisers's CVS Position: Q1 2026 in Review

Acorns Advisers increased its CVS Health (CVS) stake by 14% in Q1 2026, buying an estimated $31.3K and bringing the position to 3,409 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #98.

Acorns Advisers first reported a position in CVS in Q3 2025 and has held it in 3 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Acorns Advisers held 3,409 shares of CVS Health worth $245K as of Q1 2026.
Acorns Advisers bought 406 CVS Health shares in Q1 2026, an estimated $31.3K.
CVS Health made up ﹤0.01% of Acorns Advisers's portfolio in Q1 2026, its #98 holding.
Acorns Advisers first reported a position in CVS Health in Q3 2025 and has held it in 3 quarters since.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Acorns Advisers's 13F filing for Q1 2026, filed 14 May 2026.